YAG Laser Vitreolysis for Vitreous Floaters

Recruiting N/A Interventional Study
Posterior Vitreous Detachment Myopic Vitreopathy VISION DEGRADING MYODESOPSIA
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
50 (estimated)
Sponsor
VMR Consulting, Inc. · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to measure how the quality of life, the structure of eye, and vision change after treatment for the opacities in the gel (vitreous) that fills the center of eye which cause vision disturbances commonly called "floaters". In this study the vitreous floaters are treated using a Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser. The FDA has approved the use of this …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Only one eye per patient will be included in this study * Able and willing to give informed consent * Age ≥18 years * Suffering from symptomatic vitreous floaters * Floaters arising from either/both: * myopic vitreopathy * posterior vitreous detachment * Floaters meeting …
Contacts

Dr Jerry Sebag, MD, FACS, FRCOphth, FARVO

714-901-7777

JSebag@vmrinstitute.com

CONTACT